Cited 0 time in
Clinical feasibility of a deep learning approach for conventional and synthetic diffusion-weighted imaging in breast cancer: Qualitative and quantitative analyses
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cho, Eun | - |
| dc.contributor.author | Baek, Hye Jin | - |
| dc.contributor.author | Jung, Eun Jung | - |
| dc.contributor.author | Lee, Joonsung | - |
| dc.date.accessioned | 2024-12-10T07:00:09Z | - |
| dc.date.available | 2024-12-10T07:00:09Z | - |
| dc.date.issued | 2025-01 | - |
| dc.identifier.issn | 0720-048X | - |
| dc.identifier.issn | 1872-7727 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/74987 | - |
| dc.description.abstract | Purpose: In this study, we aimed to investigate the clinical feasibility of deep learning (DL)-based reconstruction applied to conventional diffusion-weighted imaging (cDWI) and synthetic diffusion-weighted imaging (sDWI) by comparing the DL reconstructions to cDWIs and sDWIs in patients with various breast malignancies. Methods: We retrospectively analyzed 115 patients with biopsy-proven breast malignancies who underwent breast magnetic resonance imaging from July 2022 to June 2023, including cDWI with b-value of 800 s/mm2 (cDWI800), sDWI with b-value of 1500 s/mm2 (sDWI1500), DWI using DL-based reconstruction (DL-DWI) with b-value of 800 s/mm2, and synthetic DL-DWI with b-value of 1500 s/mm2 (DL-DWI800 and sDL-DWI1500). Two radiologists independently performed the qualitative analyses using a 5-point Likert scale for all DWI sets. The quantitative analyses were also conducted for signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and cancer-to-parenchyma contrast ratio (CPR). Results: DL-DWI800 and sDL-DWI1500 provided better lesion conspicuity and thoracic muscle and rib delineation than cDWI800 and sDWI1500 (all P < 0.05). DL-DWI800 and sDL-DWI1500 showed comparable normal parenchymal signals to those of cDWI800 and sDWI1500 (all P > 0.05). sDL-DWI1500 and sDWI1500 showed no significant differences in SNR and CNR (P = 0.908, and P = 0.081, respectively). DL-DWI800 and cDWI800 were not significantly different between SNR, CNR, and CPR (all P > 0.05). Conclusions: DL-DWI outperformed cDWI and sDWI in both qualitative and quantitative analyses at the high b-values, while also achieving a shorter acquisition time. © 2024 Elsevier B.V. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Clinical feasibility of a deep learning approach for conventional and synthetic diffusion-weighted imaging in breast cancer: Qualitative and quantitative analyses | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.ejrad.2024.111855 | - |
| dc.identifier.scopusid | 2-s2.0-85210532483 | - |
| dc.identifier.wosid | 001408216000001 | - |
| dc.identifier.bibliographicCitation | European Journal of Radiology, v.182 | - |
| dc.citation.title | European Journal of Radiology | - |
| dc.citation.volume | 182 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.subject.keywordAuthor | Breast cancer | - |
| dc.subject.keywordAuthor | Deep-learning | - |
| dc.subject.keywordAuthor | Diffusion-weighted imaging | - |
| dc.subject.keywordAuthor | Synthetic diffusion-weighted imaging | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
